Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
ELECTROPHYSIOLOGICAL STUDY, BIODISTRIBUTION IN MICE, AND PRELIMINARY PET EVALUATION IN A RHESUS-MONKEY OF 1-AMINO-3-[F-18]FLUOROMETHYL-5-METHYL-ADAMANTANE (F-18-MEM) - A POTENTIAL RADIOLIGAND FOR MAPPING THE NMDA-RECEPTOR COMPLEX
Autore:
SAMNICK S; AMETAMEY S; LEENDERS KL; VONTOBEL P; QUACK G; PARSONS CG; NEU H; SCHUBIGER PA;
Indirizzi:
PAUL SCHERRER INST,CTR RADIOPHARM WPGA 6 CH-5232 VILLIGEN SWITZERLAND PAUL SCHERRER INST,CTR RADIOPHARM WPGA 6 CH-5232 VILLIGEN SWITZERLAND PAUL SCHERRER INST,PET PROGRAM CH-5232 VILLIGEN SWITZERLAND MERZ & CO GMBH FRANKFURT GERMANY
Titolo Testata:
Nuclear medicine and biology
fascicolo: 4, volume: 25, anno: 1998,
pagine: 323 - 330
SICI:
0969-8051(1998)25:4<323:ESBIMA>2.0.ZU;2-W
Fonte:
ISI
Lingua:
ENG
Soggetto:
METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; EXCITATORY AMINO-ACIDS; CENTRAL NERVOUS-SYSTEM; ANTICONVULSANT ACTIVITY; CHANNEL COMPLEX; RAT-BRAIN; MEMANTINE; MK-801; PHENCYCLIDINE;
Keywords:
[F-18] MEMANTINE; PET; NMDA RECEPTORS; PCP BINDING SITES;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
47
Recensione:
Indirizzi per estratti:
Citazione:
S. Samnick et al., "ELECTROPHYSIOLOGICAL STUDY, BIODISTRIBUTION IN MICE, AND PRELIMINARY PET EVALUATION IN A RHESUS-MONKEY OF 1-AMINO-3-[F-18]FLUOROMETHYL-5-METHYL-ADAMANTANE (F-18-MEM) - A POTENTIAL RADIOLIGAND FOR MAPPING THE NMDA-RECEPTOR COMPLEX", Nuclear medicine and biology, 25(4), 1998, pp. 323-330

Abstract

The effect of the fluorinated memantine derivative and NMDA receptor antagonist, 1-amino-3-fluoromethyl-5-methyl-adamantane (F-19-MEM), at the NMDA receptor ion channel was studied by patch clamp recording. The results showed that F-19-MEM is a moderate NMDA receptor channel blocker. A procedure for the routine preparation of the F-18-labelled analog F-18-MEM has been developed using a two-step reaction sequence. This involves the no-carrier-added nucleophilic radiofluorination of 1-[N-(tert ]-3-(toluenesulfonyloxy)methyl-5-methyl-adamantane and the subsequent cleavage of the BOC-protecting group using aqueous HCl. The F-19-MEM was obtained in 22 +/- 7% radiochemical yield (decay-corrected to EOB) in a total synthesis time including HPLC purification of 90 min. A biodistribution study after IV injection of F-18 MEM in mice showed a fast clearance of radioactivity from blood and relatively high initial uptake in the kidney and in the lung, which gradually decreased with time, The brain uptake was high (up to 3.6% ID/g, 60 min postinjection) with increasing brain-blood ratios: 2.40, 5.10, 6.33, and 9.27 at 5, 30, 60, and 120 min, respectively. The regional accumulation of the radioactivity in the mouse brain was consistent with the known distribution of the PCP recognition site. Preliminary PET evaluation of the radiotracer in a rhesus monkey demonstrated good uptake and prolonged retention in the brain, with a plateau from 35 min onwards p.i. in the NMDA receptor-rich regions (frontal cortex, striata, and temporal cortex). Delineation of the hippocampus, a region known to contain a high density of NMDA receptors, was not possible owing to the resolution of the PET tomograph. The regional brain uptake of F-18-MEM was changed by memantine and by a pharmacological dose of (+)-MK-801, indicating competition for the same binding sites. In a preliminary experiment, haloperidol, a dopamine D2 and sigma receptor antagonist, decreased the binding of F-18-MEM from the brain regions examined, suggesting that binding was also occurring to the sigma recognition sites. (C) 1998Elsevier Science Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/07/20 alle ore 07:48:17